XML 55 R42.htm IDEA: XBRL DOCUMENT
v3.21.1

SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables) | 12 Months Ended
--- | ---
Apr. 03, 2021
Segment Reporting [Abstract] |
Selected Information by Business Segment |
(In thousands) | 2021 |  | 2020 |  | 2019
Net revenues |  |  |  |  |
Plasma | $ | 333,334 |  |  | $ | 460,637 |  |  | $ | 426,781 |
Blood Center | 307,370 |  |  | 325,661 |  |  | 335,557 |
Hospital | 210,606 |  |  | 194,604 |  |  | 190,821 |
Net revenues by business unit | 851,310 |  |  | 980,902 |  |  | 953,159 |
Service (1) | 20,758 |  |  | 19,830 |  |  | 19,906 |
Effect of exchange rates | (1,605) |  |  | (12,253) |  |  | (5,486) |
Net revenues | $ | 870,463 |  |  | $ | 988,479 |  |  | $ | 967,579 |
(1) Reflects revenue for service, maintenance and parts. |  |  |  |  |
(In thousands) | 2021 |  | 2020 |  | 2019
Segment operating income |  |  |  |  |
Plasma | $ | 172,463 |  |  | $ | 225,351 |  |  | $ | 180,300 |
Blood Center | 141,962 |  |  | 159,802 |  |  | 163,628 |
Hospital | 84,066 |  |  | 80,669 |  |  | 76,338 |
Segment operating income | 398,491 |  |  | 465,822 |  |  | 420,266 |
Corporate expenses (1) | (256,751) |  |  | (255,727) |  |  | (263,603) |
Effect of exchange rates | 12,830 |  |  | 7,920 |  |  | 8,367 |
Deal amortization | (32,830) |  |  | (25,746) |  |  | (24,803) |
Impairment of assets, PCS2 accelerated depreciation and other related charges | (25,696) |  |  | (75,750) |  |  | (40,296) |
Transaction and Integration costs | (18,421) |  |  | (568) |  |  | — |
Restructuring and turnaround costs | (15,661) |  |  | (19,878) |  |  | (13,660) |
European Medical Device Regulation costs and other | (4,130) |  |  | (1,506) |  |  | — |
Litigation-related charges | (897) |  |  | 701 |  |  | (2,726) |
Gains on divestitures and sale of assets | 32,812 |  |  | 8,083 |  |  | — |
Operating income | $ | 89,747 |  |  | $ | 103,351 |  |  | $ | 83,545 |
(1) Reflects shared service expenses including quality and regulatory, customer and field service, research and development, manufacturing and supply chain, as well as other corporate support functions.
(In thousands) | 2021 |  | 2020 |  | 2019
Depreciation and amortization |  |  |  |  |
Plasma | $ | 24,093 |  |  | $ | 63,347 |  |  | $ | 61,721 |
Blood Center | 39,672 |  |  | 38,429 |  |  | 38,074 |
Hospital | 20,522 |  |  | 8,513 |  |  | 9,623 |
Total depreciation and amortization (excluding impairment charges) | $ | 84,287 |  |  | $ | 110,289 |  |  | $ | 109,418 |
(In thousands) | April 3, 2021 |  | March 28, 2020 |  | March 30, 2019
Long-lived assets(1) |  |  |  |  |
Plasma | $ | 105,599 |  |  | $ | 141,903 |  |  | $ | 192,628 |
Blood Center | 83,225 |  |  | 93,758 |  |  | 127,272 |
Hospital | 28,735 |  |  | 17,738 |  |  | 24,079 |
Total long-lived assets | $ | 217,559 |  |  | $ | 253,399 |  |  | $ | 343,979 |
(1) Long-lived assets are comprised of property, plant and equipment.
Selected information by principle operating regions is presented below:
(In thousands) | April 3, 2021 |  | March 28, 2020 |  | March 30, 2019
Long-lived assets(1) |  |  |  |  |
United States | $ | 159,749 |  |  | $ | 186,488 |  |  | $ | 269,849 |
Japan | 1,515 |  |  | 2,037 |  |  | 1,726 |
Europe | 10,384 |  |  | 10,143 |  |  | 11,200 |
Asia | 30,588 |  |  | 29,175 |  |  | 30,930 |
Other | 15,323 |  |  | 25,556 |  |  | 30,274 |
Total long-lived assets | $ | 217,559 |  |  | $ | 253,399 |  |  | $ | 343,979 |
(1) Long-lived assets are comprised of property, plant and equipment.
(In thousands) | 2021 |  | 2020 |  | 2019
United States | $ | 522,607 |  |  | $ | 646,204 |  |  | $ | 606,845 |
Japan | 77,676 |  |  | 72,218 |  |  | 69,908 |
Europe | 159,077 |  |  | 153,347 |  |  | 164,504 |
Asia | 105,820 |  |  | 109,295 |  |  | 118,700 |
Other | 5,283 |  |  | 7,415 |  |  | 7,622 |
Net revenues | $ | 870,463 |  |  | $ | 988,479 |  |  | $ | 967,579 |
Schedule of Revenues by Product Line | Net revenues by product line are as follows:
(In thousands) | 2021 |  | 2020 |  | 2019
Plasma products and services | 414,266 |  |  | 537,231 |  |  | 501,837 |
Blood Center products and services | 239,614 |  |  | 252,829 |  |  | 269,203 |
Hospital products and services | 216,583 |  |  | 198,419 |  |  | 196,539 |
Net revenues | $ | 870,463 |  |  | $ | 988,479 |  |  | $ | 967,579 |

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599 + Details
Name: | us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227 + Details
Name: | us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration